$CTCX
Carmell Corp

2022 Q2 Form 10-Q Financial Statement

#000119312522217346 Filed on August 10, 2022

View on sec.gov

Income Statement

Concept 2022 Q2 2022 Q1 2021 Q4
Revenue $0.00 $0.00 $0.00
YoY Change
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin $285.9K $535.1K $369.9K
YoY Change
% of Gross Profit
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization
YoY Change
% of Gross Profit
Operating Expenses $285.9K $535.1K $369.9K
YoY Change 4387.91% 44126.45%
Operating Profit -$285.9K -$535.1K
YoY Change 4391.37%
Interest Expense $205.3K $7.610K $5.440K
YoY Change
% of Operating Profit
Other Income/Expense, Net $130.0K
YoY Change
Pretax Income -$80.58K -$527.5K -$234.5K
YoY Change 1165.99% 43497.52%
Income Tax $266.4K $0.00
% Of Pretax Income
Net Earnings -$347.0K -$527.5K -$234.5K
YoY Change 5351.47% 43461.52%
Net Earnings / Revenue
Basic Earnings Per Share
Diluted Earnings Per Share -$17.55K -$26.68K -$11.40K
COMMON SHARES
Basic Shares Outstanding
Diluted Shares Outstanding

Balance Sheet

Concept 2022 Q2 2022 Q1 2021 Q4
SHORT-TERM ASSETS
Cash & Short-Term Investments $551.5K $594.7K $774.2K
YoY Change
Cash & Equivalents $551.5K $594.7K $774.2K
Short-Term Investments
Other Short-Term Assets $64.21K $161.4K $199.0K
YoY Change -79.63% 94.49%
Inventory
Prepaid Expenses $64.21K $199.0K
Receivables
Other Receivables
Total Short-Term Assets $615.7K $756.1K $973.2K
YoY Change 95.35% 811.38%
LONG-TERM ASSETS
Property, Plant & Equipment
YoY Change
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments $154.7M $154.5M $154.4M
YoY Change
Other Assets
YoY Change
Total Long-Term Assets $154.7M $154.5M $154.4M
YoY Change
TOTAL ASSETS
Total Short-Term Assets $615.7K $756.1K $973.2K
Total Long-Term Assets $154.7M $154.5M $154.4M
Total Assets $155.3M $155.2M $155.4M
YoY Change 49166.37% 186993.55%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable
YoY Change
Accrued Expenses $707.3K $646.9K $215.2K
YoY Change 193.57% 4618.75%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change -100.0%
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $1.060M $648.1K $330.0K
YoY Change 255.99% 995.23%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00 $0.00
YoY Change
Other Long-Term Liabilities $5.405M $5.405M $5.405M
YoY Change
Total Long-Term Liabilities $5.405M $5.405M $5.405M
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities $1.060M $648.1K $330.0K
Total Long-Term Liabilities $5.405M $5.405M $5.405M
Total Liabilities $6.465M $6.053M $5.735M
YoY Change 2071.42% 10130.67%
SHAREHOLDERS EQUITY
Retained Earnings -$5.645M -$4.763M
YoY Change
Common Stock
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity -$5.644M -$5.297M -$4.762M
YoY Change
Total Liabilities & Shareholders Equity $155.3M $155.2M $155.4M
YoY Change 49166.37% 186993.55%

Cashflow Statement

Concept 2022 Q2 2022 Q1 2021 Q4
OPERATING ACTIVITIES
Net Income -$347.0K -$527.5K -$234.5K
YoY Change 5351.47% 43461.52%
Depreciation, Depletion And Amortization
YoY Change
Cash From Operating Activities -$43.24K -$151.7K -$70.93K
YoY Change 578.81%
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities $0.00 $0.00
YoY Change
Cash From Investing Activities $0.00 $0.00
YoY Change
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 0.000 -27.79K -4.530K
YoY Change -100.0%
NET CHANGE
Cash From Operating Activities -43.24K -151.7K -70.93K
Cash From Investing Activities 0.000 0.000
Cash From Financing Activities 0.000 -27.79K -4.530K
Net Change In Cash -43.24K -179.5K -75.46K
YoY Change
FREE CASH FLOW
Cash From Operating Activities -$43.24K -$151.7K -$70.93K
Capital Expenditures
Free Cash Flow
YoY Change

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
266406
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0
alpau Proceeds From Equity Used For Funding Business Combination As A Percentage Of The Total
ProceedsFromEquityUsedForFundingBusinessCombinationAsAPercentageOfTheTotal
0.60
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
10036
dei City Area Code
CityAreaCode
646
dei Security Exchange Name
SecurityExchangeName
NASDAQ
dei Local Phone Number
LocalPhoneNumber
494-3296
CY2022Q2 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
64214
CY2021Q4 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
198983
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2022Q2 us-gaap Assets Current
AssetsCurrent
615711
dei Security12b Title
Security12bTitle
Class A Common Stock, par value $0.0001 per share
dei Trading Symbol
TradingSymbol
ALPA
CY2021Q4 us-gaap Assets Current
AssetsCurrent
973175
CY2022Q2 us-gaap Assets Held In Trust Noncurrent
AssetsHeldInTrustNoncurrent
154662029
CY2021Q4 us-gaap Assets Held In Trust Noncurrent
AssetsHeldInTrustNoncurrent
154449121
CY2022Q2 us-gaap Assets
Assets
155277740
CY2021Q4 us-gaap Assets
Assets
155422296
CY2022Q2 alpau Accrued Offering Costs
AccruedOfferingCosts
84700
CY2021Q4 alpau Accrued Offering Costs
AccruedOfferingCosts
112485
CY2022Q2 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
707300
CY2021Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
215247
CY2022Q2 us-gaap Due To Related Parties Current
DueToRelatedPartiesCurrent
1561
dei Amendment Flag
AmendmentFlag
false
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q2
dei Entity Central Index Key
EntityCentralIndexKey
0001842939
dei Entity File Number
EntityFileNumber
001-40228
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Document Type
DocumentType
10-Q
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Period End Date
DocumentPeriodEndDate
2022-06-30
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2022
dei Document Transition Report
DocumentTransitionReport
false
dei Entity Registrant Name
EntityRegistrantName
Alpha Healthcare Acquisition Corp. III
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
86-1645738
dei Entity Address Address Line1
EntityAddressAddressLine1
1177 Avenue of the Americas
dei Entity Address Address Line2
EntityAddressAddressLine2
5th Floor
dei Entity Address City Or Town
EntityAddressCityOrTown
New York
dei Entity Address State Or Province
EntityAddressStateOrProvince
NY
dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
dei Entity Small Business
EntitySmallBusiness
true
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
true
dei Entity Ex Transition Period
EntityExTransitionPeriod
false
dei Entity Shell Company
EntityShellCompany
true
CY2022Q2 us-gaap Cash
Cash
551497
CY2021Q4 us-gaap Cash
Cash
774192
CY2021Q4 us-gaap Due To Related Parties Current
DueToRelatedPartiesCurrent
2275
CY2022Q2 us-gaap Accrued Income Taxes Current
AccruedIncomeTaxesCurrent
266406
CY2021Q4 us-gaap Accrued Income Taxes Current
AccruedIncomeTaxesCurrent
0
CY2022Q2 us-gaap Liabilities Current
LiabilitiesCurrent
1059967
CY2021Q4 us-gaap Liabilities Current
LiabilitiesCurrent
330007
CY2022Q2 alpau Deferred Underwriting Fees Payable Noncurrent
DeferredUnderwritingFeesPayableNoncurrent
5405436
CY2021Q4 alpau Deferred Underwriting Fees Payable Noncurrent
DeferredUnderwritingFeesPayableNoncurrent
5405436
CY2022Q2 us-gaap Liabilities
Liabilities
6465403
CY2021Q4 us-gaap Liabilities
Liabilities
5735443
CY2022Q2 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2021Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2022Q2 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2021Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2022Q2 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
1000000
CY2021Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
1000000
CY2021Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2022Q2 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2021Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2022Q2 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2022Q2 us-gaap Preferred Stock Value
PreferredStockValue
0
CY2021Q4 us-gaap Preferred Stock Value
PreferredStockValue
0
CY2022Q2 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
0
CY2021Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
0
CY2022Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-5644828
CY2021Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-4762700
CY2022Q2 us-gaap Stockholders Equity
StockholdersEquity
-5644396
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
-4762268
CY2022Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
155277740
CY2021Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
155422296
CY2022Q2 alpau Formation General And Administrative Expenses
FormationGeneralAndAdministrativeExpenses
285876
CY2021Q2 alpau Formation General And Administrative Expenses
FormationGeneralAndAdministrativeExpenses
6365
alpau Formation General And Administrative Expenses
FormationGeneralAndAdministrativeExpenses
821018
alpau Formation General And Administrative Expenses
FormationGeneralAndAdministrativeExpenses
7576
CY2022Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-285876
CY2021Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-6365
us-gaap Operating Income Loss
OperatingIncomeLoss
-821018
us-gaap Operating Income Loss
OperatingIncomeLoss
-7576
CY2022Q2 alpau Interest And Dividend Income Non Operating
InterestAndDividendIncomeNonOperating
205296
CY2021Q2 alpau Interest And Dividend Income Non Operating
InterestAndDividendIncomeNonOperating
0
alpau Interest And Dividend Income Non Operating
InterestAndDividendIncomeNonOperating
212908
alpau Interest And Dividend Income Non Operating
InterestAndDividendIncomeNonOperating
0
CY2022Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-80580
CY2021Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-6365
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-608110
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-7576
CY2022Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
266406
CY2021Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0
CY2022Q2 us-gaap Net Income Loss
NetIncomeLoss
-346986
CY2021Q2 us-gaap Net Income Loss
NetIncomeLoss
-6365
us-gaap Net Income Loss
NetIncomeLoss
-874516
us-gaap Net Income Loss
NetIncomeLoss
-7576
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
-4762268
CY2022Q1 alpau Change In Value Of Temporary Equity Due To Dividend And Interest Earned
ChangeInValueOfTemporaryEquityDueToDividendAndInterestEarned
-7612
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
-527530
CY2022Q1 us-gaap Stockholders Equity
StockholdersEquity
-5297410
CY2022Q2 us-gaap Net Income Loss
NetIncomeLoss
-346986
CY2022Q2 us-gaap Stockholders Equity
StockholdersEquity
-5644396
CY2021Q1 us-gaap Stockholders Equity
StockholdersEquity
0
CY2021Q1 us-gaap Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
25000
CY2021Q1 us-gaap Net Income Loss
NetIncomeLoss
-1211
CY2021Q1 us-gaap Stockholders Equity
StockholdersEquity
23789
CY2021Q2 us-gaap Net Income Loss
NetIncomeLoss
-6365
CY2021Q2 us-gaap Stockholders Equity
StockholdersEquity
17424
us-gaap Profit Loss
ProfitLoss
-874516
us-gaap Profit Loss
ProfitLoss
-7576
us-gaap Investment Income Nonoperating
InvestmentIncomeNonoperating
212908
us-gaap Investment Income Nonoperating
InvestmentIncomeNonoperating
0
us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
-134769
us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
0
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
492053
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
1211
us-gaap Increase Decrease In Due To Related Parties Current
IncreaseDecreaseInDueToRelatedPartiesCurrent
-714
us-gaap Increase Decrease In Due To Related Parties Current
IncreaseDecreaseInDueToRelatedPartiesCurrent
0
us-gaap Increase Decrease In Accrued Income Taxes Payable
IncreaseDecreaseInAccruedIncomeTaxesPayable
266406
us-gaap Increase Decrease In Accrued Income Taxes Payable
IncreaseDecreaseInAccruedIncomeTaxesPayable
0
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-194910
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-6365
us-gaap Proceeds From Related Party Debt
ProceedsFromRelatedPartyDebt
0
us-gaap Proceeds From Related Party Debt
ProceedsFromRelatedPartyDebt
56820
us-gaap Payments Of Stock Issuance Costs
PaymentsOfStockIssuanceCosts
27785
us-gaap Payments Of Stock Issuance Costs
PaymentsOfStockIssuanceCosts
50455
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-27785
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
6365
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
-222695
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
0
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
774192
CY2021Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
0
CY2022Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
551497
CY2021Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
0
alpau Deferred Offering Costs Paid By Sponsor In Exchange For Issuance Of Common Stock
DeferredOfferingCostsPaidBySponsorInExchangeForIssuanceOfCommonStock
0
alpau Deferred Offering Costs Paid By Sponsor In Exchange For Issuance Of Common Stock
DeferredOfferingCostsPaidBySponsorInExchangeForIssuanceOfCommonStock
25000
alpau Offering Costs Included In Accrued Offerings Costs And Expenses
OfferingCostsIncludedInAccruedOfferingsCostsAndExpenses
0
alpau Offering Costs Included In Accrued Offerings Costs And Expenses
OfferingCostsIncludedInAccruedOfferingsCostsAndExpenses
239723
CY2022Q2 alpau Accretion Of Interest Earned In The Trust Account Accrued To Temporary Equity Shareholders
AccretionOfInterestEarnedInTheTrustAccountAccruedToTemporaryEquityShareholders
7612
CY2021Q2 alpau Accretion Of Interest Earned In The Trust Account Accrued To Temporary Equity Shareholders
AccretionOfInterestEarnedInTheTrustAccountAccruedToTemporaryEquityShareholders
0
alpau Restricted Investments Term
RestrictedInvestmentsTerm
P185D
alpau Lock In Period For Redemption Of Public Shares After Closing Of Ipo
LockInPeriodForRedemptionOfPublicSharesAfterClosingOfIpo
P24M
CY2021Q4 alpau Percentage Of Public Shares To Be Redeemed In Case Business Combination Is Not Consummated
PercentageOfPublicSharesToBeRedeemedInCaseBusinessCombinationIsNotConsummated
1
CY2021Q4 us-gaap Equity Method Investment Ownership Percentage
EquityMethodInvestmentOwnershipPercentage
0.50
CY2021Q2 us-gaap Shares Issued Price Per Share
SharesIssuedPricePerShare
10
CY2021Q4 us-gaap Minimum Net Worth Required For Compliance
MinimumNetWorthRequiredForCompliance
5000001
CY2022Q2 alpau Percentage Of Public Shares To Be Redeemed In Case Business Combination Is Not Consummated
PercentageOfPublicSharesToBeRedeemedInCaseBusinessCombinationIsNotConsummated
1
CY2022Q2 us-gaap Shares Issued Price Per Share
SharesIssuedPricePerShare
10
CY2022Q2 us-gaap Cash
Cash
551497
CY2022Q2 us-gaap Net Income Loss
NetIncomeLoss
-346986
us-gaap Net Income Loss
NetIncomeLoss
-874516
us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
<div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Concentration of Credit Risk </div></div></div> <div style="text-indent: 4%; font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Financial instruments that potentially subject the Company to a concentration of credit risk consist of a cash account in a financial institution, which at times may exceed the Federal Depository Insurance Corporation coverage limit of $250,000. The Company has not experienced losses on this account and management believes the Company is not exposed to significant risks on such account. </div></div>
alpau Offering Costs Incurred
OfferingCostsIncurred
92070
us-gaap Stockholders Equity Note Stock Split
StockholdersEquityNoteStockSplit
1:1.2
CY2022Q2 us-gaap Cash Fdic Insured Amount
CashFDICInsuredAmount
250000
CY2022Q2 us-gaap Due To Related Parties Current
DueToRelatedPartiesCurrent
1561
CY2021Q4 us-gaap Due To Related Parties Current
DueToRelatedPartiesCurrent
2275
CY2021Q2 us-gaap Related Party Transaction Amounts Of Transaction
RelatedPartyTransactionAmountsOfTransaction
0
us-gaap Related Party Transaction Amounts Of Transaction
RelatedPartyTransactionAmountsOfTransaction
0
CY2022Q2 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
3.30
CY2021Q2 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0
us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.44
us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0
CY2022Q2 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
3.30
us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.44
us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.21
CY2021Q2 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0
us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.21
CY2022Q2 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
0
CY2022Q2 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
1000000
CY2022Q2 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2022Q2 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2022Q2 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2021Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2021Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2022Q2 alpau Volume Weighted Average Price Of Shares
VolumeWeightedAveragePriceOfShares
9.2
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
0
CY2022Q2 alpau Fair Value Of Founder Shares On The Grant Date
FairValueOfFounderSharesOnTheGrantDate
5.26

Files In Submission

Name View Source Status
0001193125-22-217346-index-headers.html Edgar Link pending
0001193125-22-217346-index.html Edgar Link pending
0001193125-22-217346.txt Edgar Link pending
0001193125-22-217346-xbrl.zip Edgar Link pending
alpau-20220630.xsd Edgar Link pending
d361013d10q.htm Edgar Link pending
d361013dex311.htm Edgar Link pending
d361013dex312.htm Edgar Link pending
d361013dex321.htm Edgar Link pending
d361013dex322.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R3.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
alpau-20220630_lab.xml Edgar Link unprocessable
alpau-20220630_cal.xml Edgar Link unprocessable
alpau-20220630_pre.xml Edgar Link unprocessable
FilingSummary.xml Edgar Link unprocessable
d361013d10q_htm.xml Edgar Link completed
report.css Edgar Link pending
Show.js Edgar Link pending
alpau-20220630_def.xml Edgar Link unprocessable